WHC is still in active development. Read this to understand our approach.
depiction of SNICXCGAKADSCV-UHFFFAOYSA-N.svg
tripsit

nicotine

Check on tripsit

psychonaut

Nicotine

Check on psychonaut

isomerdesign

Nicotine

Check on isomerdesign

pubchem

Nicotine

Check on pubchem

druglab

Nicotine

Check on druglab

drugmap

Nicotine

Check on drugmap

drugmap

Nicotine

Check on drugmap

wiki

Nicotine replacement...

Check on wiki

wiki

Nicotine

Check on wiki

Data

InChI: InChI=1S/C10H14N2/c1-12-7-3-5-10(12)9-4-2-6-11-8-9/h2,4,6,8,10H,3,5,7H2,1H3

Synonyms: HMS3259E16,AKOS016843798,Nicotine [UN1654],3-[(2S)-1-methylpyrrolidin-2-yl]pyridine,ZINC391812,SDCCGMLS-0066911.P001,Nicotine polacrilex [USAN],(-)-Nicotine, PESTANAL(R), analytical standard,Niagara P.A. dust,J-500021,(2S) 3-(1-Methyl-pyrrolidin-2-yl)-pyridine,Nicotine [BSI:ISO],(S)-3-(1-methylpyrrolidin-2-yl)pyridine, 3-(N-Methylpyrrolidino)pyridine,DTXSID1020930,NICOTINE [MI],NCGC00090693-05,NICOTINE AND SALTS,Pyridine, 3-(tetrahydro-1-methylpyrrol-2-yl), (S)-,P10017,3-(2-(N-methylpyrrolidinyl))pyridine,NCGC00090693-08,a -N-methylpyrrolidine,NCGC00090693-02,Caswell No. 597,UNII-6M3C89ZY6R,(-)-1-Methyl-2-(3-pyridyl)pyrrolidine, (+-)-3-(1-Methyl-2-pyrrolidinyl)pyridine, Nikotyna [Polish],Habitrol (TN),L-3-(1-Methyl-2-pyrrolidyl)pyridine,Nicocide, SNICXCGAKADSCV-UHFFFAOYSA-N, Nico-Fume,MFCD00006369,NICOTINE [ORANGE BOOK], Beta-Pyridyl-alpha-N-methyl pyrrolidine,BDBM82070,NICOTINE-L (BASE), Habitrol (TN),BRD-K05395900-322-04-7,(S)-Nicotine,(-)-3-(N-Methylpyrrolidino)pyridine,PDSP1_000113,(-)-Nicotine, >=99% (GC), liquid,(S)-(-)-NICOTINE; 3-[(2S)-1-METHYL-2-PYRROLIDINYL] PYRIDINE,L(-)-nicotine,S(-)-Nicotine solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material,MLS001055457,BRD-K05395900-322-02-1,Nico-Fume,SBI-0050785.P003,D03365,Ortho N-4 and N-5 dusts,(S)-3-(1-Methyl-2-pyrrolidinyl)pyridine,SCHEMBL20192, Black leaf,NICOTINE COMPONENT OF COMMIT,GTPL2585, Nicoderm Patch,Prostep,Nicabate,Nicotine 1000 microg/mL in Methanol, CHEMBL440464, Nic-Sal,Nicotine betadex,beta-Pyridyl-alpha-N-methylpyrrolidine,nicotine s(-), Nicotina [Italian],PDSP1_000465, Micotine, NICOTINE AND SALTS, NCT,NCGC00090693-03,XL All Insecticide,NSC 5065,Nicorette,1-methyl-2-(3-pyridal)-pyrrolidene,ENT 3,424,Niquitin,DSSTox_CID_930,delta-Nicotine,NICOTINE [VANDF],SB12751,EC 200-193-3,Nicotine, Nictoine patch,Nicotine-D salicylate,Nicotine polacrilex, 3-(N-Methylpyrollidino)pyridine,Nikotyna,Nicoderm Cq, NSC5065, 3-[(2S)-1-methylpyrrolidin-2-yl]pyridine,NCGC00090693-06,3-((2S)-1-METHYL-2-PYRROLIDINYL)PYRIDINE, (S)-3-(N-methylpyrrolidin-2-yl)pyridine,(-)-Nicotine solution, 100 mug/mL in acetonitrile, PESTANAL(R), analytical standard,Habitrol, 3-(2-(N-methylpyrrolidinyl))pyridine,Mach-Nic,3-N-methylpyrrolidine,DTXCID50930,Nicotine alkaloid,NCGC00254095-01, (S)-(-)-NICOTINE, 3-[(2S)-1-METHYL-2-PYRROLIDINYL] PYRIDINE,RCRA waste no. P075,Nikotin [German],Pyridine, 3-(tetrahydro-1-methylpyrrol-2-yl),CAS_29790-52-1,DB00184,N0079,Emo-nik,CHEBI:17688,RCRA waste number P075,(-)-3-(1-Methyl-2-pyrrolidyl)pyridine,Pyrrolidine, 1-methyl-2-(3-pyridal)-,Micotine,DSSTox_RID_75874, (S)-3-(1-methylpyrrolidin-2-yl)pyridine,(-)-Nicotine,Flux MAAG, Black Leaf 40,Nic-Sal,NICOTINE [USP MONOGRAPH],HY-B0638, (S)-(-)-Nicotine,S-()-Nicotine-pyridine-d4,methyl-2-pyrrolidinyl)pyridine,(S)-3-(N-methylpyrrolidin-2-yl)pyridine,3-(1-methyl-2-pyrrolidinyl)-Pyridine,Exodus, Nicorette (TN),(S)-(-)--nicotine,Tox21_201814,Pyridine, 3-(1-methyl-2-pyrrolidinyl)-, (S)-,3-(N-Methylpyrollidino)pyridine, (S)-Nicotine,HMS2230H17,Pyridine, 3-[(2S)-1-methyl-2-pyrrolidinyl]-,S-(-)-Nicotine,NC00577,1-Methyl-2-(3-pyridiyl)pyrrolidine,Nicotine 10 microg/mL in Methanol,Nicotine [ISO],104062-50-2,1uw6,EPA Pesticide Chemical Code 056702,Tendust,Tox21_300174,434F7990-3240-4A43-ACEC-E6CC1E495FA0, Nicotine [BSI:ISO],NICOTINE [MART.], Tendust, L(-)-nicotine,AI3-03424, Nicotine Patch, Nicotine [UN1654] [Poison],Nicotine [UN1654] [Poison],HSDB 1107,AB00694322_12,Nicotina [Italian],NICOTINE [WHO-DD],Nicotinum,Z1954805269,DL-tetrahydronicotyrine,destruxol, Nicotine replacement patch,NICOTINE COMPONENT OF NICORETTE, (R,S)-Nicotine,3-(1-Methyl-2-pyrrolidinyl)pyridine,NICOTINE [EP MONOGRAPH],.BETA.-PYRIDYL-.ALPHA.-N-METHYL PYRROLIDINE,Z1198150037, Nicocide,Nicoderm,Nicotine (compounds related to),3-[(1R)-1beta-Methylpyrrolidine-2alpha-yl]pyridine,(-)-Nicotine solution, 1.0 mg/mL, analytical standard, for drug analysis,Nikotyna [Polish],NCGC00090693-07,3-((2S)-1-methylpyrrolidin-2-yl)pyridine,NICOTINUM [HPUS], Nicotine (compounds related to),NICOTINE [HSDB],SDCCGSBI-0050785.P004,NCGC00090693-04,Campbell's nico-soap,6M3C89ZY6R,MLS001335905,Pyridine, 3-((2S)-1-methyl-2-pyrrolidinyl)-,R)-(+)-nicotine,C00745,1-methyl-2-(3-pyridal)-Pyrrolidine, Nicotine solution, Nicotine (USP),nicotine,006N369,(S)-(-)-Nicotine,Nicotine [USP:BAN], (RS)-Nicotine, Nico-dust, BRN 0082111,(-)-.beta.-Pyridyl-.alpha.-N-methylpyrrolidine,3-(1-methylpyrrolidin-2-yl)pyridine,Nicotin, Nicotin, (2S) 3-(1-Methyl-pyrrolidin-2-yl)-pyridine,CS-3999,Nicotrol Inhaler, Nicotina, Mach-Nic,NCGC00259363-01,Nicotine (USP),Q28086552,Ortho N-4 dust,Nicotine [for single use],3-(N-Methylpyrrolidino)pyridine,Fumetobac,beta-Pyridyl-alpha-N-methyl pyrrolidine,a-N-methylpyrrolidine,Destruxol orchid spray,Pyrrolidine, 1-methyl-2-(3-pyridyl)-,SR-05000001762-5,Nicotrol,54-11-5,L-Nicotine,fumeto bac, 22083-74-5,Nicotine 100 microg/mL in Methanol, ENT 3,424,BIDD:GT0599,Nico-dust,EINECS 200-193-3,CCG-204892,CAS-54-11-5,PDSP2_000555,UN1654,Nicotina, Pyridine, 3-(1-methyl-2-pyrrolidinyl)-,CHEMBL3,NSC-5065, Nicotine [USAN],NCGC00090693-09,NCGC00090693-01, Nikotyna,PDSP2_000463,EN300-304948,SMR000059074,Ortho N-5 dust,alpha-N-methylpyrrolidine, 3-(1-Methyl-2-pyrrolidinyl)pyridine, Transdermal Nicotine,CCRIS 1637, Nikotin,[3H]nicotine, (-)-Nicotine solution, Emo-nik,DSSTox_GSID_20930,3-(1-Methyl-2-pyrollidinyl)pyridine, Nikotin [German],Nicotrol NS,Tabazur,bmse000105, Nicotine alkaloid


Estimated data

Solubility: -0.579 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)

Addictivity Prediction: 45.3% (prediction based on www.mdpi.com)

Similarities

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.